Opportunity · TB-1042
Precision components manufacturer, West Midlands
Manufacturing · Precision engineering · West Midlands
Business name withheld until information release is approved.
Business summary
A long-established precision engineering business supplying machined components to aerospace, medical device and instrumentation customers. The business operates from a freehold facility, holds AS9100 and ISO 13485 accreditation, and works to multi-year supply agreements with blue-chip primes.
The company machines complex, close-tolerance components in aluminium, titanium and specialist alloys. Production runs across 18 CNC machining centres on a two-shift pattern, with in-house inspection and a dedicated quality function. Roughly three quarters of revenue is placed under scheduled supply agreements with call-off forecasts issued quarterly, which gives strong forward visibility. The management team below the owner includes an operations director, a quality manager and a commercial manager, all of whom intend to remain post-transaction.
Financial summary
Figures are as presented by the seller and reviewed by The Brokerage.
- Turnover band
- £5m–£10m
- Turnover
- £7,180,000
- EBITDA
- £1,120,000
- Adjusted EBITDA
- £1,265,000
- Guide price
- £6,750,000
- Price basis
- Enterprise value, cash-free debt-free
Three-year summary
2024 — turnover £7.18m, EBITDA £1.12m 2023 — turnover £6.64m, EBITDA £0.97m 2022 — turnover £5.91m, EBITDA £0.82m
Recurring / contracted revenue
72% under multi-year supply agreements
Investment highlights
- AS9100 and ISO 13485 accredited across all production cells
- 72% of revenue under multi-year supply agreements
- Freehold facility with capacity for a further shift
- Complete second-tier management team in place
- EBITDA margin sustained above 15% for three consecutive years
Transaction
- Preferred transaction type
- Full sale
- Reason for sale
- The shareholder is approaching retirement and wishes to secure continuity for the workforce and customer base.
- Owner post-sale intention
- Available for a structured handover of up to twelve months, then a full exit.
- Growth opportunities
- Capacity exists for a third shift without further capital investment. Two approved-supplier positions with existing primes remain unconverted, and the medical device segment has grown 21% year on year without dedicated sales resource.
Controlled information
Further information exists and is held back. Release follows an information request, and may require further approval and an NDA.
Business identity and trading address
Registered legal name, company number and full address.
Detailed financial information
Statutory accounts, management information and the adjustment narrative.
Customer concentration
Named customers, contract terms and revenue distribution.
Key staff and contracts
Management structure, key personnel and material agreements.
Supporting documents
Seller-supplied documentation released through the Deal Room.
Opportunity record
- Reference
- TB-1042
- Region
- West Midlands
- Business type
- Private limited company
- Trading tenure
- 20+ years
- Employees
- 51–100